Neuro-Oncology Reviews

Volume 25 Number 6
31 March 2023

Home > Publications > Neuro-Oncology Reviews > Volume 25, Year 2023 > Number 6, 31 March


Arora S, Rathi AK, Singh K, Ansari FA.
Feasibility of preirradiation temozolomide in cases of high-grade gliomas: Our experience and review of literature.
J Cancer Res Ther. 2023 Mar 16;19(2):221-227. doi: 10.4103/jcrt.jcrt_942_21? PMID: 37006062. Interventional study, Review. ˍ

Horowitz T, Tabouret E, Graillon T, Salgues B, Chinot O, Verger A, Guedj E.
Contribution of nuclear medicine to the diagnosis and management of primary brain tumours.
Rev Neurol (Paris). 2023 Mar 16:S0035-3787(23)00874-3. doi: 10.1016/j.neurol.2023.03.002. PMID: 36934021. Review˰ ˍ

Kaurav M, Ruhi S, Al-Goshae HA, Jeppu AK, Ramachandran D, Sahu RK, Sarkar AK, Khan J, Ashif Ikbal AM.
Dendrimer: An update on recent developments and future opportunities for the brain tumors diagnosis and treatment.
Front Pharmacol. 2023 Mar 16;14:1159131. doi: 10.3389/fphar.2023.1159131. PMID: 37006997. Review. ˍ


Kimura S, Morita T, Hosoba K, Itoh H, Yamamoto T, Miyamoto T.
Cholesterol in the ciliary membrane as a therapeutic target against cancer.
Front Mol Biosci. 2023 Mar 16;10:1160415. doi: 10.3389/fmolb.2023.1160415. PMID: 37006607. Review. ˍ

Shala AL, Arduino I, Salihu MB, Denora N.
Quercetin and Its Nano-Formulations for Brain Tumor Therapy-Current Developments and Future Perspectives for Paediatric Studies.
Pharmaceutics. 2023 Mar 16;15(3):963. doi: 10.3390/pharmaceutics15030963. PMID: 36986827. Review. ˍ

Yang Z, Zhao C, Zong S, Piao J, Zhao Y, Chen X.
A review on surgical treatment options in gliomas.
Front Oncol. 2023 Mar 16;13:1088484. doi: 10.3389/fonc.2023.1088484. PMID: 37007123. Review. ˍ

Abed T, Ganser K, Eckert F, Stransky N, Huber SM.
Ion channels as molecular targets of glioblastoma electrotherapy.
Front Cell Neurosci. 2023 Mar 17;17:1133984. doi: 10.3389/fncel.2023.1133984. PMID: 37006466. Review. ˍ

Vetrano IG, Alongi P, Gatti L.
Editorial: Improving our understanding of the management and pathogenesis of rare and neglected tumors of the central and peripheral nervous system.
Front Oncol. 2023 Mar 17;13:1162728
. doi: 10.3389/fonc.2023.1162728. PMID: 37007150. Editorial. ˍ

Lo HW, Tapinos N.
Editorial: Epigenetics and cellular plasticity in glioblastoma.
Front Oncol. 2023 Mar 20;13:1179214
. doi: 10.3389/fonc.2023.1179214. PMID: 37020873. Editorial. ˍ

Lovibond S, Gewirtz AN, Pasquini L, Krebs S, Graham MS.
The promise of metabolic imaging in diffuse midline glioma.
Neoplasia. 2023 Mar 20;39:100896. doi: 10.1016/j.neo.2023.100896. PMID: 36944297. Review. ˍ

Mittelbronn M.
Neurooncology: 2023 update.
Free Neuropathol. 2023 Mar 20;4:4-4. doi: 10.17879/freeneuropathology-2023-4692. PMID: 37283935. Perspective. ˍ

Nafe R, Porto L, Samp PF, You SJ, Hattingen E.
Adult-type and Pediatric-type Diffuse Gliomas : What the Neuroradiologist Should Know.
Clin Neuroradiol. 2023 Mar 20. doi: 10.1007/s00062-023-01277-z. PMID: 36941392. Review. ˍ

Del Baldo G, Del Bufalo F, Pinacchio C, Carai A, Quintarelli C, De Angelis B, Merli P, Cacchione A, Locatelli F, Mastronuzzi A.
The peculiar challenge of bringing CAR-T cells into the brain: Perspectives in the clinical application to the treatment of pediatric central nervous system tumors.
Front Immunol. 2023 Mar 21;14:1142597. doi: 10.3389/fimmu.2023.1142597. PMID: 37025994. Review. ˍ

Orozco-Mera J, Peralta-Pizza F, Escobar-Vidarte O, Coll-Tello B, Ariza A.
Signaling Pathways in the Relapse of Glioblastoma.
Oncology (Williston Park). 2023 Mar 21;37(3):107-117. doi: 10.46883/2023.25920986. PMID: 36961958. Review. ˍ

Brisson L, Henrique Geraldo L, Bikfalvi A, Mathivet T.
The strange Microenvironment of Glioblastoma.
Rev Neurol (Paris). 2023 Mar 22:S0035-3787(23)00883-4. doi: 10.1016/j.neurol.2023.03.007. PMID: 36964121. Review˰ ˍ

Morales-Suárez-Varela M, Llopis-Morales A, Doccioli C, Donzelli G.
Relationship between parental exposure to radiofrequency electromagnetic fields and primarily hematopoietic neoplasms (lymphoma, leukemia) and tumors in the central nervous system in children: a systematic review.
Rev Environ Health. 2023 Mar 22. doi: 10.1515/reveh-2022-0248. PMID: 36944196. Review˰ ˍ

Suppree JS, Patel A, Keshwara SM, Krishna ST, Gillespie CS, Richardson GE, Mustafa MA, Hart S, Islim AI, Jenkinson MD, Millward CP.
Assessing the reporting quality of adult neuro-oncology protocols, abstracts, and trials: Adherence to the SPIRIT and CONSORT statements.
Neurooncol Pract. 2023 Mar 22;10(4):391-401. doi: 10.1093/nop/npad017. PMID: 37457230. Review˰ ˍ

Neumaier F, Zlatopolskiy BD, Neumaier B.
Mutated Isocitrate Dehydrogenase (mIDH) as Target for PET Imaging in Gliomas.
Molecules. 2023 Mar 23;28(7):2890. doi: 10.3390/molecules28072890. PMID: 37049661. Review. ˍ

Caverzán MD, Beaugé L, Oliveda PM, Cesca González B, Bühler EM, Ibarra LE.
Exploring Monocytes-Macrophages in Immune Microenvironment of Glioblastoma for the Design of Novel Therapeutic Strategies.
Brain Sci. 2023 Mar 24;13(4):542. doi: 10.3390/brainsci13040542. PMID: 37190507. Review. ˍ

Ius T, Sabatino G, Panciani PP, Fontanella MM, Rudà R, Castellano A, Barbagallo GMV, Belotti F, Boccaletti R, Catapano G, Costantino G, Della Puppa A, Di Meco F, Gagliardi F, Garbossa D, Germanò AF, Iacoangeli M, Mortini P, Olivi A, Pessina F, Pignotti F, Pinna G, Raco A, Sala F, Signorelli F, Sarubbo S, Skrap M, Spena G, Somma T, Sturiale C, Angileri FF, Esposito V.
Surgical management of Glioma Grade 4: technical update from the neuro-oncology section of the Italian Society of Neurosurgery (SINch®): a systematic review.
J Neurooncol. 2023 Mar 24. doi: 10.1007/s11060-023-04274-x. PMID: 36961622. Review. ˍ

Kurdi M, Mulla N, Malibary H, Bamaga AK, Fadul MM, Faizo E, Hakamy S, Baeesa S.
Immune microenvironment of medulloblastoma: The association between its molecular subgroups and potential targeted immunotherapeutic receptors.
World J Clin Oncol. 2023 Mar 24;14(3):117-130. doi: 10.5306/wjco.v14.i3.117. PMID: 37009528. Review. ˍ

Marcus R.
What Is Glioblastoma?
JAMA. 2023 Mar 24. doi: 10.1001/jama.2023.2234. PMID: 36961473. Educational. ˍ


Silvani A.
New perspectives: glioma in adult patients.
Tumori. 2023 Mar 24:3008916231159716. doi: 10.1177/03008916231159716. PMID: 36964665. Editorial. ˍ

Kusaczuk M, Zhang X.
Editorial: Targeting glioblastoma: Mechanisms of pathology and novel therapeutic strategies.
Front Mol Biosci. 2023 Mar 27;10:1181398. doi: 10.3389/fmolb.2023.1181398. PMID: 37051320. Editorial. ˍ

Frosina G.
Recapitulating the Key Advances in the Diagnosis and Prognosis of High-Grade Gliomas: Second Half of 2021 Update.
Int J Mol Sci. 2023 Mar 28;24(7):6375. doi: 10.3390/ijms24076375. PMID: 37047356. Review. ˍ

Gan HK, Day BW, Harrup R, Johns TG, Lwin Z, Scott AM, Sim HW, Koh ES.
Clinical Trials in the Brain Tumour Population: Challenges and Strategies for the Future.
Curr Oncol Rep. 2023 Mar 28. doi: 10.1007/s11912-023-01394-5. PMID: 36976462. Review˰ ˍ

Mahajan S, Schmidt MHH, Schumann U.
The Glioma Immune Landscape: A Double-Edged Sword for Treatment Regimens.
Cancers (Basel). 2023 Mar 28;15(7):2024. doi: 10.3390/cancers15072024. PMID: 37046685. Review. ˍ

Bosio A, Lombardi G.
Recurrent Glioblastoma: What Is the Route?
Cancers (Basel). 2023 Mar 29;15(7):2028. doi: 10.3390/cancers15072028. PMID: 37046689. Editorial. ˍ


Loras A, Gonzalez-Bonet LG, Gutierrez-Arroyo JL, Martinez-Cadenas C, Marques-Torrejon MA.
Neural Stem Cells as Potential Glioblastoma Cells of Origin.
Life (Basel). 2023 Mar 29;13(4):905. doi: 10.3390/life13040905. PMID: 37109434. Review. ˍ


Motomura K, Kibe Y, Ohka F, Aoki K, Yamaguchi J, Saito R.
Clinical characteristics and radiological features of glioblastoma, IDH-wildtype, grade 4 with histologically lower-grade gliomas.
Brain Tumor Pathol. 2023 Mar 29. doi: 10.1007/s10014-023-00458-5. PMID: 36988764. Review˰ ˍ

Zhou Y, Xing X, Zhou J, Jiang H, Cen P, Jin C, Zhong Y, Zhou R, Wang J, Tian M, Zhang H.
Therapeutic potential of tumor treating fields for malignant brain tumors.
Cancer Rep (Hoboken). 2023 Mar 29:e1813. doi: 10.1002/cnr2.1813. PMID: 36987739. Review. ˍ

Mengide JP, Berros MF, Turza ME, Liñares JM.
Posterior fossa tumors in children: An update and new concepts.
Surg Neurol Int. 2023 Mar 31;14:114. doi: 10.25259/SNI_43_2023. PMID: 37151431. Review. ˍ

Metz MC, Wiestler B.
Molecular imaging of gliomas.
Clin Neuropathol. 2023 Mar 31. doi: 10.5414/NP301535. PMID: 36999510. Review˰ ˍ

Nair SM, Sahu A, Dasgupta A, Puranik A, Gupta T.
Post-ictal changes presenting as late pseudoprogression on MRI and PET in a patient with diffuse glioma: Case report and brief literature review.
Neuroradiol J. 2023 Mar 31
;19714009231166105. doi: 10.1177/19714009231166105. PMID: 37002537. Case report, Review˰ ˍ